Capital Flow Monitor · Sponsors · CIK 2082735
ROC Holdings SPV II, LP
1630 COLUMBIA ROAD NW, APT. 418, WASHINGTON, DC, 20009 · 917.912.2289
Biotechnology · Limited Partnership· inc. DELAWARE true 2024
Fit score
—
Offering
—
Sold
$3.7M
% sold
—
Investors
16
Min investment
$100K
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2025-08-21 | D ·current | 506(b) | — | $3.7M | — | 16 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
-
Matthew Smith — Director, WASHINGTON, DC
6 other raises
- ROC Holdings SPV IV, LP $0 of —
- ROC Holdings SPV III, LP $0 of —
- Mazumago Holdings Ltd. $3.0M of $3.0M · 100.0%
- Ravenswood Global Partners Fund LP $46.8M of —
- Ravenswood Global Partners Fund (Cayman), LP $0 of —
- Ultimate Snooze LLC $500K of —
-
James Dahlman — Director, Atlanta, GA
2 other raises
- ROC Holdings SPV IV, LP $0 of —
- ROC Holdings SPV III, LP $0 of —
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.